| Name |
Administration |
Indication |
| Letairis® (ambrisentan) |
oral |
Pulmonary Arterial Hypertension |
| Leukine® (sargramostim) |
SAI |
Neutropenia |
| Leuprolide acetate (generic) |
SAI |
Cancer |
| Lovenox® (enoxaparin sodium) |
SAI |
Deep Vein Thrombosis |
| Lucentis® (ranibizumab) |
intraocular |
Age-related macular degeneration (AMD) |
| Lumizyme® (alglucosidase alfa) |
non-SAI |
Pompe disease |
| Lupron® (leuprolide acetate) |
SAI |
Cancer |
| Lupron Depot® (leuprolide acetate) |
SAI |
Cancer |
| Lupron Depot-PED® (leuprolide acetate) |
SAI |
Central Precocious Puberty |
| Luveris® (lutropin alfa) |
non-SAI |
Infertility |